本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioRestorative Therapies, Inc.

1.75
-0.1600-8.38%
成交量:1.14万
成交额:2.07万
市值:241.70万
市盈率:-0.08
高:1.90
开:1.85
低:1.70
收:1.91
52周最高:34.40
52周最低:1.70
股本:138.11万
流通股本:124.91万
量比:0.18
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-21.7566
每股收益(LYR):-31.6731
净资产收益率:-241.14%
总资产收益率:-118.81%
市净率:0.80
市盈率(LYR):-0.06

数据加载中...

2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/11

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/04/17

SEC问询函

Form CORRESP - Correspondence
2024/04/12

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/03

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/30

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]